로딩 중…
지수 로딩 중…
Grifols, S.A.
GRFS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
ES
ES$7.40-0.80%
2026-06-18
Price Chart
Grifols, S.A.-14.94%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $5.04B |
| Revenue | $8.44B |
| Net Income | $471M |
| Total Assets | $23.61B |
| Net Assets | $6.42B |
| Value | |
| P/E | 10.69x |
| P/B | 0.78x |
| PEG | 0.44x |
| P/S | 0.60x |
| EV/EBITDA | 8.82x |
| FCF Yield | 16.76% |
| Profitability | |
| ROE | 7.34% |
| ROA | 2.00% |
| Op. Margin | 16.88% |
| Revenue Growth | -3.24% |
| Earnings Growth | 24.24% |
| Financial Health | |
| Debt Ratio | 224.09% |
| Total Debt | $11.37B |
| FCF | $844M |
| Cash | $825M |
| Current Ratio | 2.47x |
| Net Debt/EBITDA | 5.97x |
| Dividend | |
| Div. Yield | 2.87% |
| Div. Growth | 12680.48% |
| Performance | |
| 1Y Return | -14.94% |
| 1M Return | -5.61% |
| From 52W High | -33.57% |
| 1Y MDD | -32.53% |
| Trading | |
| Volume | 962,402 shares |
| Trading Value | $7M |
| Per Share | |
| EPS | $0.64 |
| BPS | $8.38 |